Taro Kishida

Prof. Taro Kishida

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
GLGeethika Savindhi Liyanage
Geethika Savindhi Liyanage
RIRyo Inoue
Ryo Inoue
MFMina Fujitani
Mina Fujitani
TITomoko Ishijima
Tomoko Ishijima
TSTaisei Shibutani
Taisei Shibutani
SOShinji Okada
Shinji Okada
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women. Recently, various dietary interventions have been used extensively as a novel therapy against PCOS. In the present study, we show that soy isoflavone metabolites and resistant starch, together with gut microbiota modulations, were successful in decreasing the severity of PCOS-like reproductive features while increasing the expression of gut barrier markers and butyric acid in the gut. In the letrozole-induced PCOS model rats, the intake of both 0.05% soy isoflavones and 11% resistant starch, even with letrozole treatment, reduced the severity of menstrual irregularity and polycystic ovaries with a high concentration of soy isoflavones and equol in plasma. Antibiotic cocktail treatment suppressed soy isoflavone metabolism in the gut and showed no considerable effects on reducing the PCOS-like symptoms. The mRNA expression level of occludin significantly increased with soy isoflavone and resistant starch combined treatment. Bacterial genera such as Blautia, Dorea and Clostridium were positively correlated with menstrual irregularity under resistant starch intake. Moreover, the concentration of butyric acid was elevated by resistant starch intake. In conclusion, we propose that both dietary interventions and gut microbiota modulations could be effectively used in reducing the severity of PCOS reproductive features.

1 February 2008 in Obesity
Verified
Journal Article
Closed access
PDF file
TKTaro Kishida
Taro Kishida
TMTakafumi Mizushige
Takafumi Mizushige
YOYohhei Ohtsu
Yohhei Ohtsu
SIShimpei Ishikawa
Shimpei Ishikawa
MNManabu Nagamoto
Manabu Nagamoto
KEKiyoshi Ebihara
Kiyoshi Ebihara

24 January 2003 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
TKTaro Kishida
Taro Kishida
HIHiroaki Ishikawa
Hiroaki Ishikawa
MTMasaya Tsukaoka
Masaya Tsukaoka
HOHiroshi Ohga
Hiroshi Ohga
HOHiroshi Ogawa
Hiroshi Ogawa
KEKiyoshi Ebihara
Kiyoshi Ebihara

1 January 2004 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
TKTaro Kishida
Taro Kishida
MNManabu Nagamoto
Manabu Nagamoto
YOYohhei Ohtsu
Yohhei Ohtsu
MWMiho Watakabe
Miho Watakabe
DODaisuke Ohshima
Daisuke Ohshima
KEKiyoshi Ebihara
Kiyoshi Ebihara
Modulation of the activity and content of cytochrome P-450 (CYP) in hepatic microsomes may be important to human health since these enzymes activate and inactivate a wide range of xenobiotics and food components. Regulation of the inducibility of most CYPs involves transcriptional regulation and post-transcriptional mRNA stabilization. We examined in the present study the effect of dietary soy isoflavone (0-300 mg of isoflavone/kg of diet) on the mRNA abundance of rat hepatic CYP1A1, CYP1A2, CYP2B1/2, CYP2C11, CYP2E1, CYP3A1, CYP3A2 and CYP4A1 by quantitative competitive RT-PCR and real-time monitored RT-PCR. A fermented soy extract containing 155 mg/g of genistein, 127 mg/g of daidzein, and other minor isoflavones was used as the isoflavone source. The dietary soy isoflavone had no affect on the hepatic mRNA abundance of these CYPs. The results by both methods were well matched and indicate that the dietary soy isoflavone did not cause the induction of CYPs by transcriptional step-up regulation or post-transcriptional mRNA stabilization.

23 July 2006 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
TKTaro Kishida
Taro Kishida
TMTakafumi Mizushige
Takafumi Mizushige
MNManabu Nagamoto
Manabu Nagamoto
YOYohhei Ohtsu
Yohhei Ohtsu
TITohru Izumi
Tohru Izumi
KEKiyoshi Ebihara
Kiyoshi Ebihara
We examined the effect of administering an isoflavone-rich fermented soybean extract (FSBE) on the serum cholesterol concentrations in male rats and in intact and ovariectomized (OVX) female rats. Dietary FSBE decreased the serum cholesterol concentrations in intact female and OVX rats, but did not affect the concentrations in male rats. Dietary FSBE increased the hepatic total and esterified cholesterol contents in the intact female rats, but decreased them in the OVX rats. This hypocholesterolemic effect was not a simple estrogenic effect because it has appeared in some reports that estrogen administration decreased serum cholesterol both male and female rats. Dietary FSBE increased the hepatic low-density lipoprotein receptor (LDLR) gene expression in the intact female rats as has previously been reported from many studies, but did not affect that of the OVX rats. Further investigation is needed into the hypocholesterolemic mechanism of FSBE.

23 July 2009 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
TNTomofumi Nakato
Tomofumi Nakato
SYSatoshi Yamauchi
Satoshi Yamauchi
RTRyosuke Tago
Ryosuke Tago
KAKoichi Akiyama
Koichi Akiyama
MMMasafumi Maruyama
Masafumi Maruyama
YKYojiro Koba
Yojiro Koba
The syntheses of all stereoisomers of tetrasubstituted tetrahydrofuran lignan were accomplished, and the antimicrobial activity was examined. The 9,9'-diol compound bearing (7R,7'R,8R,8'R) and (7R,7'S,8R,8'R) stereochemistry showed the strongest antibacterial activity against Listeria denitrificans and Bacillus subtilis, respectively. It was also found that (-)-virgatusin bearing (7S,7'R,8S,8'S) stereochemistry had strongest antifungal activity.